You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FSGS

Showing 1 - 25 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Focal Segmental Glomerulosclerosis Trial (Metformin + Standard of Care, Placebo + Standard of Care)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • Metformin + Standard of Care
  • Placebo + Standard of Care
  • (no location specified)
Oct 13, 2023

LDL-Apheresis for FSGS CardioRenal Outcomes

Enrolling by invitation
  • Focal Segmental Glomerulosclerosis
  • No intervention
  • Cincinnati, Ohio
  • +1 more
Jan 25, 2023

Focal Segmental Glomerulosclerosis and Minimal Change Disease

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • +3 more
  • Biospecimen collection
  • Data collection
  • Ann Arbor, Michigan
    University of Michigan
Dec 6, 2022

Humanistic Burden of Focal Segmental Glomerulosclerosis and IgAN

Recruiting
  • Focal Segmental Glomerulosclerosis
  • Immunoglobulin A Nephropathy
    • Belmar, New Jersey
    • +2 more
    Apr 12, 2022

    Focal Segmental Glomerulosclerosis Trial in Dominican Republic, United States (Voclosporin)

    Terminated
    Has Results
    • Focal Segmental Glomerulosclerosis
    • Denver, Colorado
    • +22 more
    Aug 20, 2021

    Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)

    Recruiting
    • Minimal Change Disease
    • Focal Segmental Glomerulosclerosis
    • Los Angeles, California
    • +7 more
    Jul 19, 2022

    Focal Segmental Glomerulosclerosis (FSGS) Trial (VX-147)

    Not yet recruiting
    • Focal Segmental Glomerulosclerosis (FSGS)
    • (no location specified)
    Jul 13, 2023

    FSGS, Renal Transplantation, Kidney Transplantation Trial in Chapel Hill (Acthar)

    Withdrawn
    • FSGS
    • +2 more
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Aug 26, 2021

    Primary Focal Segmental Glomerulosclerosis Trial in Rochester (Obinutuzumab)

    Recruiting
    • Primary Focal Segmental Glomerulosclerosis
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 13, 2021

    Focal Segmental Glomerulosclerosis (FSGS) Trial (IXP)

    Not yet recruiting
    • Focal Segmental Glomerulosclerosis (FSGS)
    • (no location specified)
    May 9, 2023

    Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

    Recruiting
    • Bortezomib
    • +5 more
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Oct 28, 2022

    Focal Segmental Glomerulosclerosis Trial in United States (Rituximab, Plasmapheresis)

    Recruiting
    • Focal Segmental Glomerulosclerosis
    • Tuscaloosa, Alabama
    • +13 more
    Nov 16, 2021

    Adult and Child Patients and Parents of Swelling Due to

    Recruiting
    • Fluid Overload
    • +12 more
    • Interview
    • Ann Arbor, Michigan
      University of Michigan
    Aug 16, 2022

    FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

    Recruiting
    • FSGS
    • +3 more
    • Ann Arbor, Michigan
    • +3 more
    Jan 31, 2022

    FSGS Trial in Washington (Acthar)

    Recruiting
    • FSGS
    • Washington, District of Columbia
      Medstar Georgetown Transplant Institute
    Dec 10, 2020

    Focal Segmental Glomerulosclerosis Trial in Australia (Propagermanium, Placebo)

    Completed
    • Focal Segmental Glomerulosclerosis
    • Gosford, New South Wales, Australia
    • +10 more
    Jul 28, 2022

    Focal Segmental Glomerulosclerosis (FSGS) Trial in Worldwide (PF-06730512)

    Active, not recruiting
    • Focal Segmental Glomerulosclerosis (FSGS)
    • Birmingham, Alabama
    • +59 more
    Aug 17, 2022

    Understand Genetics and Clinical Course of Focal Segmental

    Terminated
    • Glomerulosclerosis, Focal Segmental
    • +2 more
    • FSGS/TR-MCD
    • Diabetic Nephropathy (DN)
    • Mesa, Arizona
    • +17 more
    Jul 17, 2021

    SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

    Not yet recruiting
    • SIOD With CKD Stage 3 Through 5
    • +3 more
    • Cyclophosphamide 1200 mg/Kg
    • +8 more
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Aug 17, 2022

    NEPTUNE Match Study

    Enrolling by invitation
    • Nephrotic Syndrome in Children
    • +7 more
    • Communication
    • Atlanta, Georgia
    • +15 more
    Jan 30, 2023

    FSGS, Focal Segmental Glomerulosclerosis, Glomerulosclerosis Trial in Worldwide (Placebo, CCX140-B)

    Completed
    • FSGS
    • +2 more
    • Phoenix, Arizona
    • +37 more
    Apr 2, 2021

    Genetic Markers for Focal Segmental Glomerulosclerosis

    Completed
    • Focal Segmental Glomerulosclerosis
    • HIV-Associated Focal Segmental Glomerulosclerosis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      A Study of Rituximab in Frontline Therapy for Glomerulonephritis

      Recruiting
      • Glomerulonephritis
        • Shanghai, China
        • +4 more
        Feb 27, 2023

        Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

        Active, not recruiting
        • Focal Segmental Glomerulosclerosis
        • +4 more
          • Boston, Massachusetts
            BIDMC
          Apr 24, 2020

          Kidney Disease Trial run by the NIDDK (N-acetyl D-mannosamine)

          Completed
          • Kidney Disease
          • N-acetyl D-mannosamine
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 26, 2023